General MedicationsORALStandard
PHENDIMETRAZINE TARTRATE
PHENDIMETRAZINE TARTRATE
Standard Dose
105MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PHENDIMETRAZINE TARTRATE is listed in Drugs@FDA under application 018074 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PHENDIMETRAZINE TARTRATE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 105MG Sponsor ACERTIS PHARMS Submission history Latest submission status date: 2020-11-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHENDIMETRAZINE TARTRATE is listed in Drugs@FDA under application 018074 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PHENDIMETRAZINE TARTRATE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 105MG Sponsor ACERTIS PHARMS Submission history Latest submission status date: 2020-11-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.